03439nam a22003494a 4500001001200000003000800012006001900020007001500039008004100054010001700095016002000112020001800132020001500150040002100165035002100186050002600207082001800233245012100251260004100372300005700413504005100470505105500521505108701576533015202663650002202815655002902837700002402866710003902890710001702929856012602946999001703072ebr10346895CaPaEBRm        u        cr cn|||||||||090224s2009    dcuaf   sb    001 0 eng    z  20090080697 z1014971622DNLM  z9781555814397  z1555814395  aCaPaEBRcCaPaEBR  a(OCoLC)64685512114aRM411b.A57556 2009eb04a615/.792422200aAntiviral researchh[electronic resource] :bstrategies in antiviral drug discovery /cedited by Robert L. LaFemina.  aWashington, DC :bASM Press,cc2009.  axiii, 373 p., [24] p. of plates :bill. (some col.).  aIncludes bibliographical references and index.0 aAntiherpesviral DNA polymerase inhibitors / Donald M. Coen -- Entry inhibitors of human immunodeficiency virus / Masanori Baba -- Human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors / Dirk Jochmans ... [et al.] -- Nucleoside analogue inhibitors of human immunodeficiency virus reverse transcriptase / J�er�ome Deval and Matthias G�otte -- Integrase as a novel target for the inhibition of human immunodeficiency virus type 1 infection : current status and future perspectives / Linos P.R. Vandekerckhove ... [et al.] -- Human immunodeficiency virus type 1 tat and rev as potential targets for drug development / Sergei Nekhai and Kuan-Teh Jeang -- Inhibitors of the human immunodeficiency virus protease / Jorge L. Martinez-Cajas and Mark A. Wainberg -- Hepatitis C virus polymerase as a target for antiviral drug intervention : non-nucleoside inhibitors / Yaya Liu, Yupeng He, and Akhteruzzaman Molla -- Nucleoside analog inhibitors of hepatitis C viral replication / Steven S. Carroll and Robert L. LaFemina --0 aAntiviral targets in orthopoxviruses / Mark N. Prichard and Earl R. Kern -- Influenza virus antiviral targets / Gillian M. Air and Wayne J. Brouillette -- Developments in the search for small-molecule inhibitors for treatment of severe acute respiratory syndrome coronavirus / Dale L. Barnard and Yohichi Kumaki -- Antiviral treatment of flaviviruses / Justin G. Julander -- Clinical aspects of hepatitis C virus infection / David Durantel and Fabien Zoulim -- Microbicides : molecular strategies for prevention of sexually transmitted viral disease / Raina N. Fichorova -- Phenotypic susceptibility assays for human immunodeficiency virus type 1 / Neil T. Parkin, Eoin Coakley, and Christos J. Petropoulos -- Metabolism of antiviral nucleosides and nucleotides / Adrian S. Ray and Michael J.M. Hitchcock -- Targeting the interferon response for antiviral therapy / Michael D. Robek -- Toll-like receptors : novel molecular targets for antiviral immunotherapy / Raymund R. Razonable, Albert Eid, and Martin Henault -- New herpes simplex virus replication targets / Sandra K. Weller.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aAntiviral agents. 7aElectronic books.2local1 aLaFemina, Robert L.2 aAmerican Society for Microbiology.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10346895zAn electronic book accessible through the World Wide Web; click to view  c32376d32376